|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.275 USD | +0.92% |
|
+9.94% | -23.93% |
| Market Cap | 2.02B 1.75B 1.63B 1.5B 2.81B 192B 2.86B 19.13B 7.51B 96.28B 7.58B 7.41B 318B | P/E 2026 * |
-6.16x | P/E 2027 * | -6.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.64B 1.42B 1.32B 1.22B 2.29B 156B 2.32B 15.55B 6.1B 78.24B 6.16B 6.02B 259B | EV / Sales 2026 * |
31x | EV / Sales 2027 * | 19x |
| Free-Float |
97.88% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ocular Therapeutix, Inc.
| 1 day | +0.82% | ||
| 1 week | +9.94% | ||
| Current month | +13.04% | ||
| 1 month | -9.46% | ||
| 3 months | -0.48% | ||
| 6 months | +2.27% | ||
| Current year | -23.93% |
| 1 week | 8.36 |  | 9.25 |
| 1 month | 8.15 | | 10.18 |
| Current year | 6.23 | | 13.03 |
| 1 year | 6.23 | | 16.44 |
| 3 years | 2 | | 16.44 |
| 5 years | 2 | | 16.44 |
| 10 years | 2 | | 24.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pravin Dugel
CEO | Chief Executive Officer | 62 | 14/04/2024 |
Jason Robins
DFI | Director of Finance/CFO | 50 | 19/01/2026 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 49 | 19/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Warden
CHM | Chairman | 57 | 30/06/2019 |
| Director/Board Member | 78 | 04/11/2012 | |
Leslie Williams
BRD | Director/Board Member | 66 | 19/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/02/26 | Sell | Executive/Senior Manager | 1,759 | 0.0008% | ||
| 23/02/26 | Sell | Executive/Senior Manager | 2,810 | 0.0013% | ||
| 23/02/26 | Sell | Chief Technology Officer | 3,057 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.92% | +9.94% | -26.47% | +136.79% | 2.02B | |
| +2.51% | +8.16% | +90.94% | +132.64% | 1,057B | |
| +0.26% | +1.98% | +49.27% | +50.70% | 625B | |
| +0.14% | +0.14% | +23.56% | +62.07% | 435B | |
| +1.24% | +4.30% | +50.75% | +39.12% | 363B | |
| +0.46% | +1.45% | +31.54% | +39.43% | 296B | |
| +0.82% | +3.98% | +8.35% | +7.13% | 249B | |
| +0.51% | +8.88% | +44.70% | +57.42% | 222B | |
| +0.34% | +1.27% | -5.10% | -50.94% | 209B | |
| +0.50% | +2.18% | +11.24% | +67.52% | 165B | |
| Average | +0.75% | +2.10% | +27.88% | +54.19% | 362.28B | |
| Weighted average by Cap. | +1.08% | +1.34% | +49.04% | +66.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 52.94M 45.79M 42.76M 39.23M 73.78M 5.04B 74.95M 502M 197M 2.53B 199M 194M 8.35B | 102M 88.65M 82.79M 75.95M 143M 9.75B 145M 971M 381M 4.89B 385M 376M 16.16B |
| Net income | -334M -289M -270M -248M -466M -31.82B -473M -3.17B -1.24B -15.95B -1.26B -1.23B -52.72B | -324M -281M -262M -240M -452M -30.87B -459M -3.07B -1.21B -15.47B -1.22B -1.19B -51.16B |
| Net Debt | -378M -327M -305M -280M -527M -35.97B -535M -3.58B -1.41B -18.03B -1.42B -1.39B -59.61B | -66M -57.09M -53.31M -48.91M -91.99M -6.28B -93.45M -625M -246M -3.15B -248M -242M -10.41B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/08/26 | US$9.235 | +0.49% | 355,692 |
| 07/08/26 | US$9.190 | +5.15% | 2,016,649 |
| 06/08/26 | US$8.740 | +2.82% | 1,594,002 |
| 05/08/26 | US$8.500 | -1.05% | 1,599,949 |
| 04/08/26 | US$8.590 | +2.26% | 2,231,589 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCUL Stock
Select your edition
All financial news and data tailored to specific country editions
